Searched by
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TC-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | ||||
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | ||||
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | ||||
|
TC-0131-2 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | ||||
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | ||||
|
TC-8031-2 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8001-1 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8026-2 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-APC |
|
|||
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | ||||
|
TC-8010-2 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | ||||
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8001-2 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8010-1 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | ||||
|
TC-8016-1 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-PE |
|
|||
|
Others | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | 4°C | ||||
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | ||||
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | 4°C | ||||
|
TC-8004-1 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | 4°C | ||||
|
TC-8003-2 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TC-8002-1 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | ||||
|
TS-M250-1 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | ||||
|
TC-8025-1 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-PE |
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | 4°C | ||||
|
TC-8016-2 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-APC |
|
|||
|
Others | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | 4°C | ||||
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | 4°C | |||||
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | 4°C | ||||
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | 4°C | ||||
|
TS-M623-2 |
H-2Kd Insulin Tetramer-LYLVCGERG-APC |
|
|||
|
Others | APC | H-2Kd | 50 tests |
0 (Contact us) |
|
| LYLVCGERG | 39-47 | 4°C | ||||
|
TS-M274-1 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| CVRVSGQGL | 4°C | |||||
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE |
|
|||
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | |||||
|
TS-M202-2 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-APC |
|
|||
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | |||||
|
TC-8003-1 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TS-M624-1 |
H-2Kd Listeria p60 Tetramer-KYGVSVQDI-PE |
|
|||
|
bacteria | PE | H-2Kd | 50 tests |
0 (Contact us) |
|
| KYGVSVQDI | 217-225 | 4°C | ||||
|
TS-M612-1 |
H-2Kb RPL18 Tetramer-KILTFDQL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| KILTFDQL | 119-126 | 4°C | ||||
|
TS-M243-1 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLDEDFYA | 4°C | |||||
|
TS-M251-2 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | |||||
|
TS-M271-1 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RVSTLRVSL | 4°C | |||||
|
TS-M603-1 |
H-2Db MuHV-4 ORF6 Tetramer-AGPHNDMEI-PE |
|
|||
|
virus | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| AGPHNDMEI | 487-495 | 4°C | ||||
|
TS-M272-1 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | |||||
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | ||||
|
TS-M271-2 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RVSTLRVSL | 4°C | |||||
|
TS-M609-1 |
H-2Kb MuHV-4 R1 Tetramer-TSINFVKI-PE |
|
|||
|
virus | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| TSINFVKI | 524-531 | 4°C | ||||
|
TS-M606-1 |
H-2Kb Influenza M1 Tetramer-MGLIYNRM-PE |
|
|||
|
virus | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| MGLIYNRM | 128-135 | 4°C | ||||
|
TS-M258-1 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | 4°C | |||||
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TS-M267-1 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | 4°C | ||||
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | |||||
|
TS-M241-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | 4°C | |||||
|
TS-M621-2 |
H-2Kb Nischarin Tetramer-TNQDFIQRL-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| TNQDFIQRL | 600-608 | 4°C | ||||
|
TS-M252-2 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | 4°C | |||||
|
TS-M623-1 |
H-2Kd Insulin Tetramer-LYLVCGERG-PE |
|
|||
|
Others | PE | H-2Kd | 50 tests |
0 (Contact us) |
|
| LYLVCGERG | 39-47 | 4°C | ||||
|
TS-M621-1 |
H-2Kb Nischarin Tetramer-TNQDFIQRL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| TNQDFIQRL | 600-608 | 4°C | ||||
|
TS-M610-1 |
H-2Kb SGK1 Tetramer-STLTYSRM-PE |
|
|||
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| STLTYSRM | 10-17 | 4°C | ||||
|
TC-8026-1 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | ||||
|
TC-8023-1 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | 4°C | ||||
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | 4°C | ||||
|
TC-8005-1 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||
|
TC-8004-2 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | 4°C | ||||
|
TS-M601-2 |
H-2Db CV-B polyprotein Tetramer-FHAGSLLVFM-APC |
|
|||
|
virus | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| FHAGSLLVFM | 268-277 | 4°C | ||||
|
TS-M616-1 |
H-2Kb ECI2 Tetramer-SSYTFPKM-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| SSYTFPKM | 280-287 | 4°C | ||||
|
TS-M259-1 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ASNASSAAK | 4°C | |||||
|
TC-8015-2 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | 4°C | ||||
|
TS-M602-2 |
H-2Db LCMV gp Tetramer-CSANNSHHYI-APC |
|
|||
|
virus | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| CSANNSHHYI | 92-101 | 4°C | ||||
|
TS-M262-2 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | 4°C | |||||
|
TS-M618-1 |
H-2Kb Histone H2B Tetramer-SVYVYKVL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| SVYVYKVL | 39-46 | 4°C | ||||
|
TS-M613-1 |
H-2Kb GLMP Tetramer-SALVFTRL-PE |
|
|||
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| SALVFTRL | 119-126 | 4°C | ||||
|
TS-M269-1 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHVPESAF | 4°C | |||||
|
TC-8012-2 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | 4°C | ||||
|
TC-8005-2 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||
|
TS-M624-2 |
H-2Kd Listeria p60 Tetramer-KYGVSVQDI-APC |
|
|||
|
bacteria | APC | H-2Kd | 50 tests |
0 (Contact us) |
|
| KYGVSVQDI | 217-225 | 4°C | ||||
|
TS-M603-2 |
H-2Db MuHV-4 ORF6 Tetramer-AGPHNDMEI-APC |
|
|||
|
virus | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| AGPHNDMEI | 487-495 | 4°C | ||||
|
TS-M255-2 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | 4°C | |||||
|
TS-M601-1 |
H-2Db CV-B polyprotein Tetramer-FHAGSLLVFM-PE |
|
|||
|
virus | PE | H-2Db | 50 tests |
0 (Contact us) |
|
| FHAGSLLVFM | 268-277 | 4°C | ||||
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | 4°C | |||||
|
TS-M619-2 |
H-2Kb PICALM Tetramer-VAFDFTKV-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| VAFDFTKV | 141-148 | 4°C | ||||
|
TS-M260-2 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | 4°C | |||||
|
TS-M276-1 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPFCVLISL | 4°C | |||||
|
TC-8029-2 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | 4°C | ||||
|
TC-8022-2 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TC-8014-1 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE |
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | ||||
|
TS-M622-1 |
H-2Kb STAT3 Tetramer-ATLVFHNL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| ATLVFHNL | 53-60 | 4°C | ||||
|
TS-M614-1 |
H-2Kb VPS16 Tetramer-VSFTYRYL-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| VSFTYRYL | 227-234 | 4°C | ||||
|
TS-M275-1 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPMIVGSPW | 4°C | |||||
|
TS-M256-1 |
HLA-A*11:01 Dengue virus NS3 Tetramer-GTSGSPIIDK-PE |
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| GTSGSPIIDK | 133-142 | 4°C | ||||
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | 4°C | |||||
|
TC-8025-2 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-APC |
|
|||
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | 4°C | ||||
|
TC-8009-1 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | 4°C | ||||
|
TS-M613-2 |
H-2Kb GLMP Tetramer-SALVFTRL-APC |
|
|||
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| SALVFTRL | 119-126 | 4°C | ||||
|
TS-M258-2 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | 4°C | |||||
|
TC-8034-1 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | ||||
|
TC-8014-2 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | ||||
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | 4°C | ||||
|
TS-M274-2 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| CVRVSGQGL | 4°C | |||||
|
TS-M273-2 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHHDQRSL | 4°C | |||||
|
TS-M259-2 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ASNASSAAK | 4°C | |||||
|
TS-M253-2 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | 4°C | |||||
|
TS-M619-1 |
H-2Kb PICALM Tetramer-VAFDFTKV-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| VAFDFTKV | 141-148 | 4°C | ||||
|
TS-M264-1 |
HLA-A*11:01 EBV BRLF1 Tetramer-ATIGTAMYK-PE |
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATIGTAMYK | 134-142 | 4°C | ||||
|
TS-M230-1 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | 4°C | |||||